Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
PaperCitations, authors & open-access status
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 30 citations, 2023 year and gold oa status.
30
Citations
2023
Year
gold
OA Status